Andes virus, an orthohantavirus endemic to South America, causes severe hantavirus cardiopulmonary syndrome associated with human-to-human transmission. No approved treatments or vaccines against this virus are available. We show that a combined treatment with 2 monoclonal antibodies protected Syrian hamsters when administered at midstage or late-stage disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462347PMC
http://dx.doi.org/10.3201/eid2710.210735DOI Listing

Publication Analysis

Top Keywords

monoclonal antibodies
8
andes virus
8
syrian hamsters
8
therapeutic efficacy
4
efficacy human
4
human monoclonal
4
antibodies andes
4
virus infection
4
infection syrian
4
hamsters andes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!